16.09.2015 Views

Clinical Pharmacology and Therapeutics

A Textbook of Clinical Pharmacology and ... - clinicalevidence

A Textbook of Clinical Pharmacology and ... - clinicalevidence

SHOW MORE
SHOW LESS
  • No tags were found...

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

PHASE II METABOLISM (TRANSFERASE REACTIONS) 25<br />

<strong>and</strong> thromboxanes are CYP450 enzymes with distinct<br />

specificities.<br />

REDUCTION<br />

Reduction requires reduced NADP-cytochrome-c reductase or<br />

reduced NAD-cytochrome b5 reductase.<br />

HYDROLYSIS<br />

Pethidine (meperidine) is de-esterified to meperidinic acid by<br />

hepatic membrane-bound esterase activity.<br />

NON-ENDOPLASMIC RETICULUM DRUG<br />

METABOLISM<br />

OXIDATION<br />

Oxidation of ethanol to acetaldehyde <strong>and</strong> of chloral to<br />

trichlorethanol is catalysed by a cytosolic enzyme (alcohol<br />

dehydrogenase) whose substrates also include vitamin A.<br />

Monoamine oxidase (MAO) is a membrane-bound mitochondrial<br />

enzyme that oxidatively deaminates primary amines to<br />

aldehydes (which are further oxidized to carboxylic acids) or<br />

ketones. Monoamine oxidase is found in liver, kidney, intestine<br />

<strong>and</strong> nervous tissue, <strong>and</strong> its substrates include catecholamines<br />

DRUG<br />

(dopamine, noradrenaline <strong>and</strong> adrenaline), tyramine, phenylephrine<br />

<strong>and</strong> tryptophan derivatives (5-hydroxytryptamine<br />

<strong>and</strong> tryptamine). Oxidation of purines by xanthine oxidase<br />

(e.g. 6-mercaptopurine is inactivated to 6-thiouric acid) is<br />

non-microsomal.<br />

REDUCTION<br />

This includes, for example, enzymic reduction of double<br />

bonds, e.g. methadone, naloxone.<br />

HYDROLYSIS<br />

Esterases catalyse hydrolytic conversions of many drugs.<br />

Examples include the cleavage of suxamethonium by plasma<br />

cholinesterase, an enzyme that exhibits pharmacogenetic variation<br />

(Chapter 14), as well as hydrolysis of aspirin (acetylsalicylic<br />

acid) to salicylate, <strong>and</strong> the hydrolysis of enalapril to enalaprilat.<br />

PHASE II METABOLISM (TRANSFERASE<br />

REACTIONS)<br />

AMINO ACID REACTIONS<br />

Glycine <strong>and</strong> glutamine are the amino acids chiefly involved in<br />

conjugation reactions in humans. Glycine forms conjugates<br />

with nicotinic acid <strong>and</strong> salicylate, whilst glutamine forms conjugates<br />

with p-aminosalicylate. Hepatocellular damage depletes<br />

the intracellular pool of these amino acids, thus restricting this<br />

pathway. Amino acid conjugation is reduced in neonates<br />

(Chapter 10).<br />

Phase I<br />

(predominantly<br />

CYP450)<br />

– Oxidation<br />

– Reduction<br />

– Hydrolysis<br />

Phase II<br />

(transferase<br />

reactions)<br />

– Acetylation<br />

– Methylation<br />

– Glucuronidation<br />

– Sulphation<br />

– Mercaptopuric<br />

acid formation<br />

– Glutathione<br />

conjugation<br />

ACETYLATION<br />

Acetate derived from acetyl coenzyme Aconjugates with several<br />

drugs, including isoniazid, hydralazine <strong>and</strong> procainamide (see<br />

Chapter 14 for pharmacogenetics of acetylation). Acetylating<br />

activity resides in the cytosol <strong>and</strong> occurs in leucocytes, gastrointestinal<br />

epithelium <strong>and</strong> the liver (in reticulo-endothelial rather<br />

than parenchymal cells).<br />

GLUCURONIDATION<br />

(a)<br />

Renal (or biliary)<br />

excretion<br />

Conjugation reactions between glucuronic acid <strong>and</strong> carboxyl<br />

groups are involved in the metabolism of bilirubin, salicylates<br />

O<br />

H<br />

N<br />

NH<br />

O<br />

Phase I<br />

HO<br />

O<br />

H<br />

N<br />

NH<br />

O<br />

Phase II<br />

CO 2 H<br />

O<br />

OH<br />

O<br />

O<br />

H<br />

N<br />

NH<br />

O<br />

O<br />

O<br />

OH<br />

OH<br />

O<br />

Phenobarbital<br />

p-Hydroxy<br />

phenobarbital<br />

p-Hydroxy phenobarbital<br />

glucuronide<br />

(b)<br />

Figure 5.1: (a) Phases I <strong>and</strong> II of drug metabolism. (b) A specific example of phases I <strong>and</strong> II of drug metabolism, in the case of<br />

phenobarbital.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!